| Q47607769 | Advances in treatment of systemic sclerosis |
| Q37987428 | Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases |
| Q73273980 | Autologous haemopoietic stem cell transplantation |
| Q54104613 | Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. |
| Q63214396 | Autologous hematopoietic stem cell transplantation for autoimmune diseases |
| Q33632260 | Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. |
| Q34109010 | Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease |
| Q35553325 | Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity |
| Q24792552 | Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells |
| Q74165624 | BMT beats autoimmune disease |
| Q34109147 | Bone marrow transplantation in the treatment of systemic sclerosis |
| Q33338475 | Collection of hematopoietic stem cells from patients with autoimmune diseases. |
| Q44511400 | Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation |
| Q33706249 | From autoimmunity to stem cell transplantation |
| Q33911434 | Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease |
| Q41393398 | Hematopoietic stem and progenitor cells can be enriched by implanting biomaterial into spatium intermusculare |
| Q34208626 | High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes |
| Q74824493 | How can treatment of systemic sclerosis be improved?. By setting up a national database of all cases and entering patients into trials. UK Scleroderma Study Group |
| Q37929621 | Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis |
| Q36666422 | Immunological applications of stem cells in type 1 diabetes |
| Q40892440 | Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases? |
| Q35204115 | Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. |
| Q77352574 | Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis |
| Q47180993 | Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma |
| Q35552384 | Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation |
| Q30929503 | New strategies for BMT, organ transplantation, and regeneration therapy |
| Q35953258 | Non-myeloablative stem cell transplantation for autoimmune diseases |
| Q34108644 | Novel therapeutic strategies in scleroderma |
| Q28080076 | Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement |
| Q36815081 | Scleroderma lung: pathogenesis, evaluation and current therapy |
| Q33632194 | Stem cell transplantation for autoimmune diseases |
| Q74209992 | Stem cell transplantation for autoimmune diseases |
| Q33867000 | Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives |
| Q33608580 | Stem cell transplantation--a treatment for severe rheumatic diseases?--A review |
| Q34552765 | Stem cells in clinical practice: applications and warnings |
| Q89314104 | Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation |
| Q80552104 | The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis |
| Q37194001 | Treatment of systemic sclerosis: potential role for stem cell transplantation. |
| Q81235668 | [Therapy of systemic sclerosis] |